Abstract
Zein nanoparticles as a carrier system for BMP6-derived peptide were prepared by liquid–liquid phase separation procedure and characterized with SEM, DLS, FTIR and thermogravimetric methods. After peptide encapsulation, nanoparticle size increased from 236.3 ± 92.2 nm to 379.4 ± 116.8 nm. The encapsulation efficiency of peptide was 72.6% and the release of peptide from Zein nanoparticles was partly sustained in trypsin containing phosphate buffered saline (pH 7.4) for up to 14 days. Peptide-loaded nanoparticles showed similar cell viability compared with blank ones. ALP activity of C2C12 cells treated with peptide-loaded nanoparticles (500 µg/mL) was evaluated 7, 14, 21 and 28 days after culture. In peptide-loaded nanoparticles, ALP activity was significantly higher (p
Author supplied keywords
Cite
CITATION STYLE
Hadavi, M., Hasannia, S., Faghihi, S., Mashayekhi, F., Homazadeh, H., & Mostofi, S. B. (2018). Zein nanoparticle as a novel BMP6 derived peptide carrier for enhanced osteogenic differentiation of C2C12 cells. Artificial Cells, Nanomedicine and Biotechnology, 46(sup1), 559–567. https://doi.org/10.1080/21691401.2018.1431649
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.